StonvexLoading…
StonvexStonvexStonvexCore line items from W's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.93B | $12.46B | $9.12B | $6.00B |
Operating Income | $-11.00M | $17.00M | $-67.00M | $-105.00M |
Net Income | $-105.00M | $-313.00M | $-197.00M | $-98.00M |
EPS (Diluted) | $-0.80 | $-2.44 | $-1.54 | $-0.77 |
Total Assets | $2.87B | $3.44B | $3.12B | $3.28B |
Total Liabilities | $5.71B | $6.22B | $5.88B | $6.00B |
Cash & Equivalents | $1.00B | $1.48B | $1.17B | $1.33B |
Free Cash Flow OCF − CapEx | $-77.00M | $464.00M | $287.00M | $159.00M |
Shares Outstanding | 131.00M | 128.00M | 128.00M | 127.00M |